BioCentury
ARTICLE | Clinical News

Pollinex Quattro Tree: Preliminary Phase I data

December 5, 2005 8:00 AM UTC

Preliminary data from a Phase I trial showed reduced allergenicity with modified allergans (allergoids) compared with natural unmodified allergans. About 4%, 0.36% and 0.33% of natural allergans produ...